ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)

University of Oran 1

Status: Not yet enrolling

Conditions: Cholecystitis; Gallbladder Dyskinesia; Pancreatitis Biliary; Polyps; Cholecystectomy; Gall Stone; Adults

Study type: Observational

Funder types: Other

Identifiers

NCT06481007

Univ-2024-0017

Details and patient eligibility

About

Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices.

In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.

Full description

This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria. This information is crucial for benchmarking existing practices, pinpointing areas for enhancement, and ultimately improving patient safety and surgical effectiveness.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 18 years and older.
• Undergoing cholecystectomy.
• Surgery performed in public or private hospitals in Algeria.
• Surgery performed from January 1, 2025, to June 30, 2025.

Exclusion criteria

• Patients younger than 18 years.
• Patients refusing to participate.
• Cholecystectomy performed for Gallbladder cancer.
• Cholecystectomy performed outside the inclusion period.
• Cholecystectomies performed in conjunction with other major surgeries.

Trial design

500 participants in 1 patient group

Cholecystectomy

Description:

patient opérated ( cholecystectomy) and responding to inclusion criteria